Novavax, Inc. (NVAX)
NASDAQ • Healthcare
Last close at November 11, 2026 at 21:00 UTC
Metrics Over Time
Where the Money Goes
Q3 2026In plain terms: out of every $100 in revenue, Novavax, Inc. currently loses $46.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Novavax topped consensus on both EPS and revenue in the third fiscal quarter of 2026 (period ended September 30, 2026), reported November 5, 2026, with EPS of -$0.19 topping the -$0.35 estimate by $0.16 as revenue of $68.3 million topped the $50.4 million estimate (+35.4%). On a year-over-year basis, revenue slipped 3% to about $68.3 million from roughly $70.4 million, while net income improved 85% to a loss of about $31.4 million from a loss of roughly $202.4 million, alongside EPS up 85% from -$1.25 a year ago. Profitability showed a gross margin of roughly 66% as gross profit reached about $44.8 million, while operating income was a loss of roughly $31.3 million, corresponding to an operating margin near -46%. Cash generation was negative, with operating cash flow of roughly -$91.6 million. For the next period, consensus calls for EPS of $0.07 on revenue of $123.2 million.
About Novavax, Inc.
Novavax, Inc. develops and commercializes vaccines within the biotechnology sector, centered on preventing serious infectious diseases. The company trades on the NASDAQ Global Select Market under NVAX and generated $1.1 billion of revenue in FY2025, with its work spanning marketed and developing vaccine programs for several respiratory viruses.
Today's Snapshot
The session opened with NVAX 2.5% lower at 9.73, while its sector was flat.
Trading Volume
Below 10d avg (6.0M)
1.6M
vs S&P 500 Today
Strong Underperformance
-7.47%
Updated: November 12, 2026 at 15:47 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$9.34 - $10.34Sell
- RSI (14)42.50Neutral
- Stochastic %K (14, 3, 3)40.67Neutral
- MACD Level (12, 26)-0.21Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.